Trials / Completed
CompletedNCT04084483
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 238 (actual)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the safety, efficacy, optimum dosage, and dosing regimen of K-161 in adult subjects with moderate to severe dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-161 | K-161 alternate dosage |
| OTHER | Placebo (Vehicle) | Placebo solution |
Timeline
- Start date
- 2019-08-04
- Primary completion
- 2020-01-09
- Completion
- 2020-01-09
- First posted
- 2019-09-10
- Last updated
- 2023-03-15
- Results posted
- 2023-03-15
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04084483. Inclusion in this directory is not an endorsement.